Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis.

ABSTRACT:

Objective

To address the efficacy and safety of proactive therapeutic drug monitoring of biologic drugs for patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis.

Design

Systematic review and meta-analysis.

Data sources

Medline, Embase, Central, and CINAHL, from database inception to 23 May 2024.

Eligibility criteria for selecting studies

Trials including people with inflammatory bowel disease, inflammatory arthritis, and psoriasis were selected. Selected trials also randomly assigned people to either proactive therapeutic drug monitoring of tumour necrosis factor-alpha inhibitors or other biologic drugs in the intervention group, and to either no therapeutic drug monitoring or standard care in the control group. Reviewers worked indep

SUBMITTER: Zeraatkar D 

PROVIDER: S-EPMC11579540 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature